AstraZeneca Kft. secures contract for Antineoplastic and Immunomodulation Agents - anti -cancer agents for drug programs - Enhertu (Trastuzumab Deruxtecan)

Posted On: 2025-02-10

Poland, Feb. 10 -- Poland based AstraZeneca Kft. has secured contract from 4. Wojskowy Szpital Kliniczny z Poliklinika Samodzielny Publiczny Zaklad Opieki Zdrowotnej we Wroclawiu for Antineoplastic and Immunomodulation Agents - anti -cancer agents for drug programs - Enhertu (Trastuzumab Deruxtecan). The value of the contract is worth 141066662 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

AstraZeneca Kft. secures contract for Antineoplastic and Immunomodulation Agents - anti -cancer agents for drug programs - Enhertu (Trastuzumab Deruxtecan)